2011 Fiscal Year Final Research Report
Effect of erythropoietin and clinical-used drug in periventricular leukomalasia
| Project/Area Number |
21591419
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Embryonic/Neonatal medicine
|
|---|
| Research Institution | Nagoya City University |
|---|
Principal Investigator |
MIZUNO Keisuke 名古屋市立大学, 大学院・医学研究科, 研究員 (00405177)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HIDA Hideki 名古屋市立大学, 大学院・医学研究科, 教授 (00305525)
|
|---|
| Research Collaborator |
MASUDA Tadashi 名古屋市立大学, 大学院・医学研究科, 助教 (10423641)
MISUMI Sachiyo 名古屋市立大学, 大学院・医学研究科, 助教 (70529148)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Keywords | 脳性麻痺 / 長期モデル / iPS細胞 / 神経系分化誘導 / 細胞移植 / 前駆細胞 |
|---|
| Research Abstract |
It was revealed by the assessment of motor functions(rotarrod, motor deficit score and cylinder test) that a rat model of periventricular leukomalasia(PVL) is appropriate to the model for a longer time. It became possible to induce oligodendrocytes and its progenitors(OPC) from mouse ES cells/iPS cells in vitro as the donor cells to PVL. In transplantation of iPS cells-derived OPC to PVL model rat, grafted cells can survive well in the white matter, revealing that some substances such as trophic factors will be needed for better survival rate.
|
